Search research articles
Contact Us
Filters
Showing results (171-180 of 222) with videos related to
Page
of 23
Sort By:
JHEP Reports : Innovation in Hepatology
|
June 18, 2021
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
BMC Gastroenterology
|
October 17, 2007
Meta-analyses of FibroTest diagnostic value in chronic liver disease
Thierry Poynard, Rachel Morra, Philippe Halfon, et al.
Gastroenterology
|
October 31, 2002
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection
Laurent Alric, Vincent Di-Martino, Janik Selves, et al.
Gastro Hep Advances
|
August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants
Raluca Pais, Pascal Lebray, Geraldine Rousseau, et al.
European Journal of Gastroenterology & Hepatology
|
December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
Thierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Comparative Hepatology
|
January 23, 2003
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
Philippe Halfon, Françoise Imbert-Bismut, Djamila Messous, et al.
BMC Gastroenterology
|
April 24, 2010
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
Thierry Poynard, Pascal Lebray, Patrick Ingiliz, et al.
Journal of Hepatology
|
May 29, 2013
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
Thierry Poynard, Joseph Moussalli, Mona Munteanu, et al.
Journal of Hepatology
|
November 20, 2012
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study
Thierry Poynard, Jordi Bruix, Eugene R Schiff, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 222) with videos related to
Sort By:
Page
of 23
JHEP Reports : Innovation in Hepatology
|
June 18, 2021
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
BMC Gastroenterology
|
October 17, 2007
Meta-analyses of FibroTest diagnostic value in chronic liver disease
Thierry Poynard, Rachel Morra, Philippe Halfon, et al.
Gastroenterology
|
October 31, 2002
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection
Laurent Alric, Vincent Di-Martino, Janik Selves, et al.
Gastro Hep Advances
|
August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants
Raluca Pais, Pascal Lebray, Geraldine Rousseau, et al.
European Journal of Gastroenterology & Hepatology
|
December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
Thierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Comparative Hepatology
|
January 23, 2003
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
Philippe Halfon, Françoise Imbert-Bismut, Djamila Messous, et al.
BMC Gastroenterology
|
April 24, 2010
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
Thierry Poynard, Pascal Lebray, Patrick Ingiliz, et al.
Journal of Hepatology
|
May 29, 2013
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
Thierry Poynard, Joseph Moussalli, Mona Munteanu, et al.
Journal of Hepatology
|
November 20, 2012
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study
Thierry Poynard, Jordi Bruix, Eugene R Schiff, et al.
Page
of 23